Box Hill Private Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$259K Sell
990
-3
-0.3% -$769 0.19% 63
2026
Q2
$250K Buy
993
+16
+2% +$3.44K 0.2% 61
2026
Q1
$212K Buy
977
+6
+0.6% +$1.33K 0.21% 63
2025
Q4
$222K Buy
+971
New +$221K 0.22% 55

Other funds holding ABBV

Box Hill Private Wealth's ABBV Position: Q3 2026 in Review

Box Hill Private Wealth reduced its AbbVie (ABBV) stake by 0.3% in Q3 2026, selling an estimated $769 and leaving 990 shares worth $259K. The position accounts for 0.19% of the portfolio, ranked #63.

Box Hill Private Wealth first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 49 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Box Hill Private Wealth held 990 shares of AbbVie worth $259K as of Q3 2026.
  • Box Hill Private Wealth sold 3 AbbVie shares in Q3 2026, an estimated $769.
  • AbbVie made up 0.19% of Box Hill Private Wealth's portfolio in Q3 2026, its #63 holding.
  • Box Hill Private Wealth first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 49 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Box Hill Private Wealth's 13F filing for Q3 2026, filed 5 Oct 2026.